Open in app

Sign in

Write

Sign in

Elaia
Elaia

328 Followers

Home

About

Published in

Elaia

·2 days ago

Mablink Bioscience and Elaia: A Symbiotic Partnership

Written by Florian Denis with assistance from Anya Brochier, David Sourdive, Louisa Mesnard, and Marc Rougier. Mablink Bioscience, a French biotech company engaged in the fight against cancer through the development of Antibody Drug Conjugates (ADCs), i.e., anti-cancer drugs that target cancer cells without affecting healthy cells — has been…

Venture Capital

10 min read

Mablink Bioscience and Elaia: A Symbiotic Partnership
Mablink Bioscience and Elaia: A Symbiotic Partnership
Venture Capital

10 min read


Published in

Elaia

·Nov 29

The Impact of GenAI from the Lens of Bain, Google and L’Oréal at Elaia

Featuring voices from Bain, Google and L’Oréal Written by Anya Brochier with assistance from Louisa Mesnard and Marc Rougier. Extracted from a panel moderated by Sébastien Lefebvre featuring speakers: Cyrille Vincey (Partner, Bain Consulting), Nico Gaviola (Director Data Analytics and Sales, Google), and Jean-Paul Paoli (GenAI Business Transformation Director, L’Oréal). As deep science is a part of…

AI

4 min read

The Impact of GenAI from the lens of Bain, Google and L’Oréal at Elaia
The Impact of GenAI from the lens of Bain, Google and L’Oréal at Elaia
AI

4 min read


Published in

Elaia

·Oct 26

What Impact Could Generative AI Have on Drug Discovery? Part II

By Florian Denis, with assistance from Marc Rougier, Louisa Mesnard and Anya Brochier We’re back with Part II of our investigation into the intersection of GenAI and drug discovery. In Part I we looked at historical examples and the building blocks of this intersection, now in part II we look…

Healthcare

7 min read

What Impact Could Generative AI Have on Drug Discovery? Part II
What Impact Could Generative AI Have on Drug Discovery? Part II
Healthcare

7 min read


Published in

Elaia

·Oct 24

What Impact Could Generative AI Have on Drug Discovery? Part I

By Florian Denis, with assistance from Marc Rougier, Louisa Mesnard and Anya Brochier The sonic boom caused by the eruption of generative AI (GenAI) into our vocabulary has asked us to imagine the impact of this new technology on the world of healthcare and specifically on drug discovery. While most…

Healthcare

6 min read

What impact could Generative AI have on drug discovery? Part I
What impact could Generative AI have on drug discovery? Part I
Healthcare

6 min read


Published in

Elaia

·Sep 25

Elaia’s 2022 Annual Sustainability Report is here!

Following an ESG (environmental, social, governance) framework, our third edition of Elaia’s Annual Sustainability Report evaluates how Elaia and our portfolio companies can adhere to ESG guidelines. From reducing our impact on the environment, to building sustainable relationships with our communities and developing responsible leadership, Elaia is committed to integrating…

Sustainability

1 min read

Elaia’s 2022 Annual Sustainability Report is here!
Elaia’s 2022 Annual Sustainability Report is here!
Sustainability

1 min read


Published in

Elaia

·Jul 7

Learnings from backing international deep tech

By Maxime Lhoustau with the help of Saish Rane, Anne-Sophie Carrese, Sébastien Lefebvre, Julien Macquet & Clément Vanden Driessche Introduction Xavier, before being an investor, started as a mathematician and through his vision and ambition to back technological entrepreneurs, our passion for investing in deep tech was born. Anne-Sophie, meanwhile, started…

Deeptech

9 min read

Learnings from backing international deep tech
Learnings from backing international deep tech
Deeptech

9 min read


Published in

Elaia

·Jun 21

Startup Perspectives: From Product-Market-Fit to €10 million in sales

At Elaia, we have been backing ambitious tech B2B founders for 20 years and one thing that cannot be understated is that sales are important. …

Sales

6 min read

Startup Perspectives: From Product-Market-Fit to €10 million in sales
Startup Perspectives: From Product-Market-Fit to €10 million in sales
Sales

6 min read


Published in

Elaia

·Mar 28

The Finance Behind Startup Investing

by Xavier Lazarus Introduction These chapters around “the finance behind startup investing” aim at sharing learnings based on 20 years of experience gathered working at Elaia. In recent years, VC has gained quite the reputation with many SaaS startups reaching the stratosphere and becoming household names. Nevertheless, it is a domain…

Venture Capital

11 min read

The Finance Behind Startup Investing
The Finance Behind Startup Investing
Venture Capital

11 min read


Published in

Elaia

·Feb 9

Entrepreneur Stories: Why would a foreign entrepreneur set up their business in France?

By Armelle de Tinguy, Saish Rane with help from Marc Rougier At first look, France doesn’t seem like the birthplace of entrepreneurship despite having invented the word. …

Deep Tech Startups

7 min read

Entrepreneur Stories: Why would a foreign entrepreneur set up their business in France?
Entrepreneur Stories: Why would a foreign entrepreneur set up their business in France?
Deep Tech Startups

7 min read


Published in

Elaia

·Feb 3

Investing in Spain: opportunities and sunny outlooks

(and we’re not even talking about the weather) — By Agathe Destruhaut with the help of Christophe Primault, Sébastien Lefebvre, Xavier Lazarus, Julien Macquet, Marc Rougier and Saish Rane. 1. Why we chose to invest in Spain From entering a nascent market… (pre-2010) Elaia’s strong interest in Spain is not accidental. Shortly after launching Elaia, Xavier Lazarus, who is half-Catalan, noticed a growing opportunity in this emerging tech ecosystem.

Spain

14 min read

Investing in Spain: opportunities and sunny outlooks
Investing in Spain: opportunities and sunny outlooks
Spain

14 min read

Elaia

Elaia

328 Followers

Backing tech disruptors

Following
  • Mauricio Mejia

    Mauricio Mejia

  • Nicolas Cole

    Nicolas Cole

  • Aaron Dinin, PhD

    Aaron Dinin, PhD

  • Joe Procopio

    Joe Procopio

  • David O.

    David O.

See all (1,328)

Help

Status

About

Careers

Blog

Privacy

Terms

Text to speech

Teams